Does BUMETANIDE Cause Interstitial lung disease? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Interstitial lung disease have been filed in association with BUMETANIDE (Bumetanide). This represents 0.3% of all adverse event reports for BUMETANIDE.
6
Reports of Interstitial lung disease with BUMETANIDE
0.3%
of all BUMETANIDE reports
3
Deaths
4
Hospitalizations
How Dangerous Is Interstitial lung disease From BUMETANIDE?
Of the 6 reports, 3 (50.0%) resulted in death, 4 (66.7%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BUMETANIDE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does BUMETANIDE Cause?
Acute kidney injury (490)
Drug ineffective (186)
Hypotension (182)
Fatigue (173)
Dehydration (170)
Dyspnoea (147)
Dizziness (129)
Weight increased (113)
Cardiac failure (97)
Renal impairment (89)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which BUMETANIDE Alternatives Have Lower Interstitial lung disease Risk?
BUMETANIDE vs BUPIVACAINE
BUMETANIDE vs BUPIVACAINE\BUPIVACAINE ANHYDROUS
BUMETANIDE vs BUPIVACAINE\EPINEPHRINE
BUMETANIDE vs BUPIVACAINE\MELOXICAM
BUMETANIDE vs BUPRENORPHINE